Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PORACTANT ALFA for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where PORACTANT ALFA was used for Off label use.

Most Reported Side Effects for PORACTANT ALFA

Side Effect Reports % Deaths Hosp.
Neonatal hypoxia 118 20.9% 6 7
Off label use 71 12.6% 17 14
Ill-defined disorder 48 8.5% 41 0
Bradycardia neonatal 45 8.0% 6 5
Pulmonary haemorrhage 38 6.7% 27 3
Drug ineffective 34 6.0% 11 12
Endotracheal intubation complication 32 5.7% 4 2
Product complaint 31 5.5% 5 9
Infantile apnoea 30 5.3% 1 1
Pulmonary haemorrhage neonatal 27 4.8% 12 5
Product administration error 26 4.6% 1 0
Neonatal respiratory failure 25 4.4% 21 4
Pneumothorax 21 3.7% 8 2
Cyanosis neonatal 20 3.6% 0 0
Product quality issue 20 3.6% 4 0

Other Indications for PORACTANT ALFA

Neonatal respiratory distress syndrome (412) Product used for unknown indication (99) Respiratory distress (8) Acute respiratory distress syndrome (5) Premature baby (5) Respiratory failure (5)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

PORACTANT ALFA Full Profile All Off label use Drugs PORACTANT ALFA Demographics PORACTANT ALFA Timeline